Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Late buying fuels indices
Wed, 8 May Closing

Indian equity markets had a volatile trading session today. The indices began the day's proceedings on a positive note and maintained the momentum for most of the morning session. While the afternoon session saw some profit booking at higher levels, buying activity resumed thereafter pushing the indices higher. While the BSE Sensex today closed higher by 101 points, the NSE-Nifty closed higher by 26 points. Both the BSE Mid Cap index and the BSE Small Cap also notched gains of 0.5% each. Gains were largely seen in banking and FMCG stocks.

As regards global markets, Asian equity markets closed in the green today while European indices have also opened firm. The rupee was trading at Rs 54.14 to the dollar at the time of writing.

Pharma stocks closed mixed today. While Cadila Healthcare and Lupin closed firm, Ranbaxy and Biocon were at the receiving end. Ranbaxy announced results for the first quarter ended March 2013 (December ending company). Net sales declined by 34% YoY during the quarter, due to Lipitor exclusivity in 1QCY12, which was not present this quarter. Base sales registered double digit growth. Operating margins declined to 6.2% during the quarter, against 28.9% in 1QCY12. This was again due to the presence of high margin Lipitor during 1QCY12. The company reported profit of Rs 1.3 bn in 1QCY12 down by 90% YoY largely because of the fall in operating profits and surge in interest costs.

PSU banking stocks closed mixed today. While Corporation Bank and Punjab National Bank (PNB) found favour, Bank of India and State Bank of India (SBI) closed into the red. Corporation Bank announced results for the fourth quarter and year ended March 2013. The bank posted a marginal growth in net profits on account of higher provisioning and lower margins during the quarter. While total advances were up by 18% YoY as of March 2013, deposits increased by 22% YoY. Total provisions during the quarter rose by 22% YoY. The net interest margin declined to 2.29% in FY13 from 2.48% in FY12. Going forward, the bank will need to expand its CASA base substantially. It has been shedding its costly bulk deposits; however this still remains at elevated levels. Going forward it plans to focus on increasing its CASA base by adding branches and also focus on NPA recovery efforts and keeping gross NPAs below 2%. It also plans to open branches in rural areas to be able to meet its priority sector lending targets which are still below mandated levels.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Late buying fuels indices". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.